Astellas: Agreed To Buy OSI Pharmaceuticals For $4 Billion
May 16 2010 - 9:13PM
Dow Jones News
Astellas Pharma Inc. (4503.TO) said Monday it will buy OSI
Pharmaceuticals Inc. (OSIP) for $4 billion, bringing an initially
hostile takeover attempt to an agreement by raising its original
offer price by over 10%.
Japan's second largest pharmaceutical maker said in a statement
OSI's board unanimously supports its takeover.
In an attempt to expand its cancer drug business, Astellas
launched a tender offer for OSI in March by offering $52 a share.
Under their takeover agreement, the offer price has been raised to
$57.50 and the bid will be extended.
-By Kazuhiro Shimamura, Dow Jones Newswires; 813-6269-2790;
kazuhiro.shimamura@dowjones.com
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Apr 2023 to Apr 2024